What is Januvia 25 mg, film-coated tablets used for?

( ARTG ) JANUVIA (sitagliptin phosphate monohydrate) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus as: - monotherapy when metformin is considered inappropriate due to intolerance; or - in combination with other anti-hyperglycaemic agents, including insulin,(see 5.1 PHARMACODYNAMIC PROPERTIES, Clinical trials, 4.5 INTERACTIONS WITH OTHER MEDICINES AND OTHER FORMS OF INTERACTIONS for available data on diffe

What are the side effects of Januvia 25 mg, film-coated tablets?

You can help ensure medicines are safe by reporting the side effects you experience. You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems

Can Januvia 25 mg, film-coated tablets be used during pregnancy?

( AHT ) For the active ingredient sitagliptin You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.

Who manufactures Januvia 25 mg, film-coated tablets?

MSD Merck Sharp & Dohme AG (CH)

What ATC class does Januvia 25 mg, film-coated tablets belong to?

Januvia 25 mg, film-coated tablets: ATC A10BH01. ATC is the WHO Anatomical Therapeutic Chemical classification — it groups drugs by organ system and pharmacological mechanism.

OTC

Januvia 25 mg, film-coated tablets

Data updated: 2026-04-11

Available in:

🇨🇿🇩🇪🇬🇧🇵🇹🇸🇰🇹🇷

Form

—

Dosage

—

Route

—

Storage

—

About This Product

Manufacturer

User Reviews

Reviews reflect personal experiences and are not medical advice. Always consult your doctor.